Table 1.

MT protein expression 3 days after LM infection with and without CR treatment^‡

Strain	Spleen			Liver
	Control*	LM	LM + CR	–	LM	LM + CR
B6-WT	ND**	4.1 ± 0.5	3.1 ± 0.9	2.5 ± 0.5	7.4 ± 3.3	6.3 ± 2.8
B6-MTTGN	ND	4.8 ± 0.9	6.0 ± 0.5a	2.2 ± 0.4	20.4 ± 3.0b,d	24.4 ± 2.3c,d

^‡Mean ± SD of μg MT per mg protein; *Non-infected mice; ND not detectable

^aSpleens from B6-TTGN mice differed (p = 0.0082) from those of B6-WT mice after LM + CR

^bLivers from B6-TTGN mice differed (p = 0.0072) from those of B6-WT mice after LM

^cLivers from B6-TTGN mice differed (p < 0.001) from those of B6-WT mice after LM + CR

^dLivers from LM and LM + CR treated B6-TGGN mice differed (p < 0.001) from non-treated (control) B6-MTTGN mice